Sort
82,697 grants matching “vaccine development”
Pacific NorthWest Regional Center of Excellence (PNWRCE)
$8,113,612Jay A Nelson · Oregon Health & Science University · U54 · FY2011 · AI
Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) - DOC
$8,111,177James J. Korelitz · Westat, Inc. · U01 · FY2012 · HD
Adol. Medicine Trials Network for HIV/AIDS Interventions
$8,108,754James J Korelitz · Westat, Inc. · U01 · FY2007 · HD
DEVELOPMENT OF RICIN VACCINE FORMULATION
$8,104,724Robert Brey · Soligenix, Inc. · N01 · FY2016 · AI
CENTRAL LABORATORY FOR THE HIV VACCINES TRAILS NETWORK
$8,104,153Duke University · U01 · FY2002 · AI
CENTRAL LABORATORY FOR THE HIV VACCINES TRAILS NETWORK
$8,089,486Duke University · U01 · FY2001 · AI
Tulane National Primate Research Center
$8,076,590Lee Hamm · Tulane University Of Louisiana · P51 · FY2015 · OD
Advanced Development of an Ebola Vaccine
$8,069,468Maria Grazia Pau · Janessen Vaccines And Prevention, Bv · N01 · FY2014 · AI
Vaccines to Interrupt Malaria Transmission: Clinical Development
$8,068,044Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Pacific NorthWest Regional Center of Excellence (PNWRCE)
$8,064,974Jay A Nelson · Oregon Health & Science University · U54 · FY2010 · AI
TULANE NATINAL PRIMATE RESEARCH CENTER
$8,038,661Tulane University Of Louisiana · P51 · FY2004 · RR
Tulane National Primate Research Center
$8,033,738Lee Hamm · Tulane University Of Louisiana · P51 · FY2013 · OD
Development of immunology and immunization strategies that induce broadly pro
$8,028,634Dennis R. Burton · Scripps Research Institute, The · UM1 · FY2017 · AI
Vaccine Immunology Program
$8,027,794Adrian McDermott · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
The Baltimore Longitudinal Study of Aging
$8,005,297Eleanor M Simonsick · National Institute On Aging · ZIA · FY2022 · AG
Statistical and Data Management Center for the AIDS Clinical Trials Group
$8,004,235Michael David Hughes · Harvard School Of Public Health · UM1 · FY2013 · AI
CIVIC: University of Georgia Center for Influenza Vaccine Research in High Risk Populations
$8,000,000Ted Ross · University Of Georgia · N01 · FY2025 · AI
CIVIC: University of Georgia Center for Influenza Vaccine Research in High Risk Populations
$8,000,000Ted Ross · University Of Georgia · N01 · FY2019 · AI
Vaccine and Treatment Evaluation Units: Wolbachia-Infected Aedes aegypti Mosquitos in Reducing Arboviral Infection Brazil
$7,999,643Nadine Rouphael · Emory University · N01 · FY2020 · AI
Coordinating and Data Sharing Center - R&D of Vaccines and Antibodies for Pandemic Preparedness (ReVAMPP)
$7,994,888Gregory D Sempowski · Research Triangle Institute · UG3 · FY2024 · AI
Collaborative Influenza Vaccine Innovation Centers (CIVICs)
$7,993,900Tony Moody · Duke University · N01 · FY2025 · AI
Development of ProtollinTM Plague Vaccine
$7,992,403Id Biomedical Corporation Of Washington · UC1 · FY2004 · AI
The Development and Evaluation of Pan-Coronavirus Vaccines
$7,990,794Michael S. Diamond · Washington University · P01 · FY2022 · AI
CLINICAL DEVELOPMENT OF A NOROVIRUS GASTROENTERITIS VACCINE
$7,985,144Takeda Vaccines Inc · · FY2011 · Department of the Army
Clinical Trails to Evaluate H5N1 Influenza Variant Vaccines
$7,985,002Theresa Engel · Leidos Biomedical Research, Inc. · N01 · FY2024 · AI